These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3899817)

  • 21. Metabolic disorders in diabetes.
    Fraser R
    Br Med J; 1972 Dec; 4(5840):591-6. PubMed ID: 4629981
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between serum glucose level and the metabolic clearance rate of glucose in non-insulin-dependent diabetes mellitus.
    Revers RR; Kolterman OG; Olefsky JM
    Diabetes; 1983 Jul; 32(7):627-32. PubMed ID: 6345242
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of insulin sensitivity in vivo.
    Bergman RN; Finegood DT; Ader M
    Endocr Rev; 1985; 6(1):45-86. PubMed ID: 3884329
    [No Abstract]   [Full Text] [Related]  

  • 24. [The functional role of membrane lipids in the mechanisms for realizing the effect of insulin].
    Saatov TS; Isaev EI; Ergashova MZh
    Probl Endokrinol (Mosk); 1990; 36(4):18-22. PubMed ID: 2235928
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Nerup J; Koch C
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the relationship between plasma insulin concentration and efficiency of glucose uptake in normal and mildly diabetic subjects.
    Reaven GM; Silvers A; Farquhar JW
    Diabetes; 1970 Aug; 19(8):571-8. PubMed ID: 5449149
    [No Abstract]   [Full Text] [Related]  

  • 27. Reproducibility and comparability of insulin sensitivity indices measured by stable-label intravenous glucose tolerance test.
    Hovorka R; Bannister P; Eckland DJ; Halliday D; Murley DN; Rees SE; Young MA
    Diabet Med; 1998 Mar; 15(3):234-46. PubMed ID: 9545125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sugar transport across the blood-brain barrier.
    Buschiazzo PM; Terrell EB; Regen DM
    Am J Physiol; 1970 Nov; 219(5):1505-13. PubMed ID: 5473139
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of free fatty acids in glucose homeostasis.
    Ruderman NB; Toews CJ; Shafrir E
    Arch Intern Med; 1969 Mar; 123(3):299-313. PubMed ID: 4303992
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of insulin infusions on the glucose kinetics in alloxan-steptozotocin diabetic dogs.
    Issekutz B; Issekutz TB; Elahi D; Borkow I
    Diabetologia; 1974 Aug; 10(4):323-8. PubMed ID: 4278073
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of variations in basal plasma glucose concentration on glucose utilization (M) and metabolic clearance (MCR) rates during insulin clamp studies in patients with non-insulin-dependent diabetes mellitus.
    Doberne L; Greenfield MS; Rosenthal M; Widstrom A; Reaven G
    Diabetes; 1982 May; 31(5 Pt 1):396-400. PubMed ID: 6759255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of diabetes in the Chinese hamster.
    Gerritsen GC; Dulin WE
    Diabetologia; 1967 Apr; 3(2):74-84. PubMed ID: 5630193
    [No Abstract]   [Full Text] [Related]  

  • 33. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans.
    Butler PC; Caumo A; Zerman A; O'Brien PC; Cobelli C; Rizza RA
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E548-60. PubMed ID: 8476033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic interrelations of glucose and lactate in unanesthetized normal and diabetic dogs.
    Forbath N; Hetenyi G
    Can J Physiol Pharmacol; 1970 Feb; 48(2):115-22. PubMed ID: 5415613
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma concentrations and rates of plasma clearance and production of cortisol and corticosterone in healthy persons and in subjects with asymptomatic and clinical diabetes mellitus.
    Hüther KJ; Scholz HR
    Horm Metab Res; 1970 Nov; 2(6):357-63. PubMed ID: 4940072
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on adipose tissue from obese patients with or without diabetes mellitus. II. Basal and insulin-stimulated glucose metabolism.
    Björntorp P
    Acta Med Scand; 1966 Feb; 179(2):229-34. PubMed ID: 5932061
    [No Abstract]   [Full Text] [Related]  

  • 37. Single-pass dual-label indicator method. Blood-to-brain transport of glucose and short-chain monocarboxylic acids.
    Puchowicz MA; Xu K; LaManna JC
    Methods Mol Med; 2003; 89():265-76. PubMed ID: 12958426
    [No Abstract]   [Full Text] [Related]  

  • 38. Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus.
    Powrie JK; Smith GD; Shojaee-Moradie F; Sönksen PH; Jones RH
    Am J Physiol; 1991 Jun; 260(6 Pt 1):E897-904. PubMed ID: 2058666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symposium I: hormone-fuel interactions in normal and diabetic man. The liver as site of insulin and glucagon action in normal, diabetic and obese humans.
    Felig P; Wahren J
    Isr J Med Sci; 1975 Jun; 11(6):528-39. PubMed ID: 1099051
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
    Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
    Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.